Sara E. Oliver

6.1k total citations · 3 hit papers
54 papers, 2.9k citations indexed

About

Sara E. Oliver is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Sara E. Oliver has authored 54 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Health and 19 papers in Epidemiology. Recurrent topics in Sara E. Oliver's work include Vaccine Coverage and Hesitancy (22 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Bacterial Infections and Vaccines (10 papers). Sara E. Oliver is often cited by papers focused on Vaccine Coverage and Hesitancy (22 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Bacterial Infections and Vaccines (10 papers). Sara E. Oliver collaborates with scholars based in United States, Canada and France. Sara E. Oliver's co-authors include Grace M. Lee, H. Keipp Talbot, Megan Wallace, José R. Romero, Beth P. Bell, Kathleen Dooling, Mary E. Chamberland, Nancy McClung, Julia W. Gargano and Mona Marin and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Sara E. Oliver

54 papers receiving 2.8k citations

Hit Papers

The Advisory Committee on Immunization Practices’ Interim... 2020 2026 2022 2024 2020 2021 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
    2020 394 citations Sara E. Oliver, Julia W. Gargano et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
    2021 371 citations Julia W. Gargano, Megan Wallace et al. MMWR Morbidity and Mortality Weekly Report profile →
  3. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
    2021 130 citations Jessica R. MacNeil, Karen R. Broder et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara E. Oliver United States 20 1.6k 1.0k 677 384 378 54 2.9k
Tom T. Shimabukuro United States 37 2.5k 1.6× 1.6k 1.6× 1.2k 1.8× 209 0.5× 873 2.3× 92 4.8k
Bradley K. Ackerson United States 26 2.1k 1.3× 929 0.9× 1.1k 1.7× 396 1.0× 222 0.6× 100 3.4k
Julianne Gee United States 32 1.9k 1.2× 1.9k 1.8× 1.7k 2.5× 216 0.6× 865 2.3× 74 4.6k
John M. McLaughlin United States 29 2.3k 1.5× 1.3k 1.2× 1.1k 1.7× 726 1.9× 173 0.5× 105 4.3k
Sarah E. Wilson Canada 23 851 0.5× 671 0.6× 577 0.9× 179 0.5× 135 0.4× 79 1.7k
Tyra Grove Krause Denmark 28 847 0.5× 648 0.6× 1.1k 1.6× 297 0.8× 138 0.4× 100 2.5k
Noam Barda Israel 17 2.6k 1.7× 1.1k 1.1× 302 0.4× 563 1.5× 347 0.9× 45 3.7k
Lina S. Sy United States 30 1.1k 0.7× 669 0.6× 2.3k 3.4× 139 0.4× 236 0.6× 124 3.6k
Megan Wallace United States 19 1.4k 0.9× 936 0.9× 343 0.5× 386 1.0× 284 0.8× 41 2.5k
Salaheddin M. Mahmud Canada 38 560 0.4× 460 0.4× 2.7k 4.0× 239 0.6× 1.1k 3.0× 177 5.3k

Countries citing papers authored by Sara E. Oliver

Since Specialization
Citations

This map shows the geographic impact of Sara E. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Oliver more than expected).

Fields of papers citing papers by Sara E. Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Oliver. The network helps show where Sara E. Oliver may publish in the future.

Co-authorship network of co-authors of Sara E. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Sara E. Oliver. A scholar is included among the top collaborators of Sara E. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara E. Oliver. Sara E. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leung, Jessica, et al.. (2024). Characteristics of reported mumps cases in the United States: 2018–2023. Vaccine. 42(25). 126143–126143. 4 indexed citations
2.
Meaney‐Delman, Dana, Kara N.D. Polen, Tara C. Jatlaoui, et al.. (2024). Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic. Vaccine. 42. 125644–125644. 3 indexed citations
3.
Masters, Nina B., Inga Holmdahl, Chirag K. Kumar, et al.. (2024). Real-Time Use of a Dynamic Model To Measure the Impact of Public Health Interventions on Measles Outbreak Size and Duration — Chicago, Illinois, 2024. MMWR Morbidity and Mortality Weekly Report. 73(19). 430–434. 2 indexed citations
4.
5.
Oliver, Sara E., Heidi M. Soeters, Arthur Reingold, et al.. (2023). Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae — 10 U.S. Jurisdictions, 2011–2018. MMWR Morbidity and Mortality Weekly Report. 72(15). 386–390. 3 indexed citations
6.
Moulia, Danielle, Megan Wallace, Lauren E. Roper, et al.. (2023). Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023. MMWR Morbidity and Mortality Weekly Report. 72(24). 657–662. 20 indexed citations
7.
Oliver, Sara E., Megan Wallace, Evelyn Twentyman, et al.. (2023). Development of COVID-19 vaccine policy — United States, 2020–2023. Vaccine. 42. 125512–125512. 10 indexed citations
8.
Fleming-Dutra, Katherine E., Lauren Head Zauche, Lauren E. Roper, et al.. (2023). Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants. Obstetrics and Gynecology Clinics of North America. 50(2). 279–297. 16 indexed citations
9.
Oliver, Sara E., Heidi M. Soeters, Arthur Reingold, et al.. (2023). Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease—United States, 2008–2019. Clinical Infectious Diseases. 76(11). 1889–1895. 14 indexed citations
10.
Wallace, Megan, Jennifer P. Collins, Heidi L. Moline, et al.. (2022). Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies. PLoS ONE. 17(12). e0278624–e0278624. 6 indexed citations
11.
Paul, Prabasaj, Kathleen Dooling, Sara E. Oliver, et al.. (2022). Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States. Vaccine. 40(14). 2134–2139. 12 indexed citations
12.
Demeke, Hanna B., Angela M. Thompson‐Paul, Tonya Williams, et al.. (2021). Real-Time CDC Consultation during the COVID-19 Pandemic—United States, March–July, 2020. International Journal of Environmental Research and Public Health. 18(14). 7251–7251. 6 indexed citations
13.
Dooling, Kathleen, Mona Marin, Megan Wallace, et al.. (2020). The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020. MMWR Morbidity and Mortality Weekly Report. 69(5152). 1657–1660. 278 indexed citations
14.
McClung, Nancy, Mary E. Chamberland, Kathy Kinlaw, et al.. (2020). The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020. American Journal of Transplantation. 21(1). 420–425. 19 indexed citations
15.
16.
Oliver, Sara E., Julia W. Gargano, Mona Marin, et al.. (2020). The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 school year. 69. 1 indexed citations
17.
Cope, Anna B., Victoria Mobley, Sara E. Oliver, et al.. (2018). Ocular Syphilis and Human Immunodeficiency Virus Coinfection Among Syphilis Patients in North Carolina, 2014–2016. Sexually Transmitted Diseases. 46(2). 80–85. 18 indexed citations
18.
Oliver, Sara E., Anna B. Cope, Jessica L. Rinsky, et al.. (2017). Increases in Ocular Syphilis—North Carolina, 2014–2015. Clinical Infectious Diseases. 65(10). 1676–1682. 39 indexed citations
19.
20.
Oliver, Sara E., Gretchen A. Cloud, Pablo J. Sánchez, et al.. (2009). Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. Journal of Clinical Virology. 46. S22–S26. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tom T. Shimabukuro Breakdown of academic impact, for papers by Bradley K. Ackerson Breakdown of academic impact, for papers by Julianne Gee Breakdown of academic impact, for papers by John M. McLaughlin Breakdown of academic impact, for papers by Sarah E. Wilson Breakdown of academic impact, for papers by Tyra Grove Krause Breakdown of academic impact, for papers by Noam Barda Breakdown of academic impact, for papers by Lina S. Sy Breakdown of academic impact, for papers by Megan Wallace Breakdown of academic impact, for papers by Salaheddin M. Mahmud
Rankless by CCL
2026